Adhera Therapeutics Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

1.16K

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	252.00K	176.00K	231.58%
Dec 31, 2018	76.00K	-	-
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Nabriva Therapeutics	29.56M
Affimed	6.29M
Alzex Neuropharma	4.73M
DNAPrint Genomics	1.93M
Endonovo Therapeutics	255.72K

Revenue Rankings

Adhera Therapeutics News

3 years ago - Adhera Therapeutics to Collaborate with Alberta Diabetes Institute, University of Alberta to Initiate Clinical Trial of MLR-1023 in Type 1 Diabetes - GlobeNewsWire
3 years ago - Adhera Therapeutics Announces CEO, Senior Management Changes, Plans for NASDAQ Uplist - GlobeNewsWire
4 years ago - Adhera Therapeutics Signs Letter of Intent to Acquire CD71-Targeted Cancer Therapy Paclitaxel Gallium Transferrin - GlobeNewsWire
4 years ago - Adhera Therapeutics Appoints Trond K. Waerness as Chairman of the Board, Company Focuses on Uplist to NASDAQ - GlobeNewsWire
4 years ago - Adhera Therapeutics Names Preeminent Diabetes Pioneer Dr. Jean Buteau to Scientific Advisory Board - GlobeNewsWire
4 years ago - Adhera Therapeutics Announces Uplisting to OTCQB Venture Marketplace - GlobeNewsWire
4 years ago - Adhera Therapeutics Receives Notice of Allowance for New Canadian Patent Covering MLR-1019 for Dyskinesia and Related Disorders - GlobeNewsWire
4 years ago - Adhera Therapeutics Announces Appointment of Dr. Zahed Subhan to Board of Directors - GlobeNewsWire

More News